Eiko Lifescience

  • Market Cap: Micro Cap
  • Industry: Specialty Chemicals
  • ISIN: INE666Q01016
  • NSEID:
  • BSEID: 540204
INR
51.98
0.5 (0.97%)
BSENSE

Jun 18

BSE+NSE Vol: 3.81 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1002696,
    "name": "Eiko Lifescience",
    "stock_name": "Eiko Lifescience",
    "full_name": "Eiko Lifesciences Ltd",
    "name_url": "stocks-analysis/eiko-lifescience",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "51.98",
    "chg": 0.5,
    "chgp": "0.97%",
    "dir": 1,
    "prev_price": "51.48",
    "mcapval": "74.57 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540204,
    "symbol": "",
    "ind_name": "Specialty Chemicals",
    "ind_code": 5,
    "indexname": "India SENSEX",
    "isin": "INE666Q01016",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "3.81 k",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/eiko-lifescience-1002696-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Eiko Lifesciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/eiko-lifesciences-ltd-is-rated-sell-3955910",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/EikoLifescience_mojoScore_3955910.png",
        "date": "2026-04-21 10:10:03",
        "description": "Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 April 2026, providing investors with the most up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Eiko Lifesciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/eiko-lifesciences-ltd-is-rated-sell-3941598",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/EikoLifescience_mojoScore_3941598.png",
        "date": "2026-04-10 10:10:03",
        "description": "Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Eiko Lifesciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/eiko-lifesciences-ltd-is-rated-sell-3923881",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/EikoLifescience_mojoScore_3923881.png",
        "date": "2026-03-30 10:10:02",
        "description": "Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 March 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      }
    ],
    "total": 7,
    "sid": "1002696",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/eiko-lifesciences-1002696"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "27-May-2026",
      "details": "Newspaper publication dated 27th May 2026 for Audited Financial Results (Standalone & Consolidated) of the Company for the Quarter and Year ended 31st March 2026 approved by the Board at their meeting held on 26th May 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "26-May-2026",
      "details": "Re-appointment of M/s NP Rajput & Co as Internal Auditor for FY 2026-27 at the Board Meeting held on 26th May 2026.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Board Meeting",
      "datetime": "26-May-2026",
      "details": "Audited Financial Results (Standalone and Consolidated) for quarter and year ended 31st March 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Eiko Lifesciences Ltd has declared <strong>2%</strong> dividend, ex-date: 20 Sep 17",
          "dt": "2017-09-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Eiko Lifesciences Ltd has announced <strong>2:3</strong> rights issue, ex-date: 07 Jul 23",
          "dt": "2023-07-07",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

27-May-2026 | Source : BSE

Newspaper publication dated 27th May 2026 for Audited Financial Results (Standalone & Consolidated) of the Company for the Quarter and Year ended 31st March 2026 approved by the Board at their meeting held on 26th May 2026.

Announcement under Regulation 30 (LODR)-Change in Management

26-May-2026 | Source : BSE

Re-appointment of M/s NP Rajput & Co as Internal Auditor for FY 2026-27 at the Board Meeting held on 26th May 2026.

Board Meeting Outcome for Outcome Of The Board Meeting

26-May-2026 | Source : BSE

Audited Financial Results (Standalone and Consolidated) for quarter and year ended 31st March 2026

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Eiko Lifesciences Ltd has declared 2% dividend, ex-date: 20 Sep 17

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

Eiko Lifesciences Ltd has announced 2:3 rights issue, ex-date: 07 Jul 23